A Phase II study of all‐trans‐retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma

G. P. Kalemkerian, M. R. Jiroutek, D. S. Ettinger, J. A. Dorghi, D. H. Johnson, M. Mabry

Research output: Contribution to journal › Article › peer-review

Disciplines

@article{8d9578fd71364559a0c86b3b85bd92af,

title = "A Phase II study of all‐trans‐retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma",

author = "Kalemkerian, {G. P.} and Jiroutek, {M. R.} and Ettinger, {D. S.} and Dorghi, {J. A.} and Johnson, {D. H.} and M. Mabry",

year = "2000",

month = nov,

day = "9",

doi = "/10.1002/(SICI)1097-0142(19980915)83:6<1102::AID-CNCR8>3.0.CO;2-9",

language = "American English",

volume = "83",

journal = "Cancer",

}

TY - JOUR

T1 - A Phase II study of all‐trans‐retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma

AU - Kalemkerian, G. P.

AU - Jiroutek, M. R.

AU - Ettinger, D. S.

AU - Dorghi, J. A.

AU - Johnson, D. H.

AU - Mabry, M.

PY - 2000/11/9

Y1 - 2000/11/9

UR - https://cufind.campbell.edu/pharmacy/1707

UR - https://doi.org/10.1002/(SICI)1097-0142(19980915)83:6<1102::AID-CNCR8>3.0.CO;2-9

U2 - /10.1002/(SICI)1097-0142(19980915)83:6<1102::AID-CNCR8>3.0.CO;2-9

DO - /10.1002/(SICI)1097-0142(19980915)83:6<1102::AID-CNCR8>3.0.CO;2-9

M3 - Article

VL - 83

JO - Cancer

JF - Cancer

ER -